Cleared Special

K192259 - Philips IntelliSite Pathology Solution

K192259 is an FDA 510(k) clearance for Philips IntelliSite Pathology Solution, manufactured by Philips Electronics Nederland B.V.. The device is a Class 2 Pathology device with product code PSY cleared through the Special 510(k) pathway after a 30-day FDA review.

K192259 · Philips Electronics Nederland B.V. · Pathology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2019
Decision
30d
Days
Class 2
Risk

K192259 is an FDA 510(k) clearance for the Philips IntelliSite Pathology Solution. Classified as Whole Slide Imaging System (product code PSY), Class II - Special Controls.

Submitted by Philips Electronics Nederland B.V. (Best, NL). The FDA issued a Cleared decision on September 20, 2019 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 864.3700 - the FDA pathology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K192259

510(k) Number K192259 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 21, 2019
Decision Date September 20, 2019
Days to Decision 30 days
Submission Type Special
Review Panel Pathology (PA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
48d faster than avg
Panel avg: 78d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

PSY Device Classification - Class 2, Special Controls

Product Code PSY Whole Slide Imaging System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.3700
Definition The Whole Slide Imaging System Is An Automated Digital Slide Creation, Viewing, And Management System Intended As An Aid To The Pathologist To Review And Interpret Digital Images Of Surgical Pathology Slides Prepared From Formalin-fixed, Paraffin-embedded (ffpe) Tissue. The System Generates Digital Images That Would Otherwise Be Appropriate For Manual Visualization By Conventional Brightfield Microscopy. The Whole Slide Imaging System Is Not Intended For Use With Slides Prepared From Frozen Tissue, Cytology, And Non-ffpe Hematopathology Specimens (e.g., Peripheral Blood Smear).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Pathology devices follow this clearance model.

Regulatory Peers - PSY Whole Slide Imaging System

All 22
Devices cleared under the same product code (PSY) and FDA review panel - the closest regulatory comparables to K192259.
NanoZoomer S360MD Slide scanner system
K213883 · Hamamatsu Photonics K.K. · Sep 2022
Philips IntelliSite Pathology Solution
K203845 · Philips Medical Systems Nederland B.V. · Sep 2021
MDPC-8127
K203364 · Barco N.V. · Apr 2021
Aperio AT2 DX System
K190332 · Leica Biosystems Imaging, Inc. · May 2019
Philips IntelliSite Pathology Solution
K172174 · Philips Medical Systems Nederland B.V. · Oct 2017
Philips IntelliSite Pathology Solution
DEN160056 · Philips Medical Systems Nederland B.V. · Apr 2017
K192259 · Philips IntelliSite Pathology Solution
Download PDF FDA Summary Philips Electronics N…